Phenotypic and functional abnormalities of bone marrow-derived dendritic cells in systemic lupus erythematosus

Arthritis Research and Therapy

Volumn 12, Issue 3, 2010, Pages

  Nie, Ying J ^a   Mok, Mo Y ^a   Chan, Godfrey C F ^a   Chan, Albert W ^a   Jin, Ou ^a   Kavikondala, Sushma ^a   Lie, Albert K W ^a   Lau, Chak S ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CD135 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; HYDROXYCHLOROQUINE; INTERLEUKIN 4; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; ALPHA INTERFERON; CCR7 PROTEIN, HUMAN; FLT3 LIGAND PROTEIN; MEMBRANE PROTEIN;

ADULT; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DEVELOPMENTAL STAGE; FEMALE; HUMAN; HUMAN CELL; MALE; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; CASE CONTROL STUDY; DRUG EFFECT; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; ANTIGENS, CD40; ANTIGENS, CD86; BONE MARROW CELLS; CASE-CONTROL STUDIES; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHENOTYPE; RECEPTORS, CCR7;

EID: 77952255629     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3018     Document Type: Article

References (50)

1. Hoffman RW. T cells in the pathogenesis of systemic lupus erythematosus. Clin Immunol 2004, 113:4-13. 10.1016/j.clim.2004.05.001, 15380523.
2. Yurasov S, Wardemann H, Hammersen J, Tsuiji M, Meffre E, Pascual V, Nussenzweig MC. Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med 2005, 201:703-711. 10.1084/jem.20042251, 2212839, 15738055.
3. Berkun Y, Verbovetski I, Ben-Ami A, Paran D, Caspi D, Krispin A, Trahtemberg U, Gill O, Naparstek Y, Mevorach D. Altered dendritic cells with tolerizing phenotype in patients with systemic lupus erythematosus. Eur J Immunol 2008, 38:2896-2904. 10.1002/eji.200838342, 18958888.
4. Migita K, Miyashita T, Maeda Y, Kimura H, Nakamura M, Yatsuhashi H, Ishibashi H, Eguchi K. Reduced blood BDCA-2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus. Clin Exp Immunol 2005, 142:84-91. 10.1111/j.1365-2249.2005.02897.x, 1809479, 16178860.
5. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997, 388:782-787. 10.1038/42030, 9285591.
6. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998, 392:245-252. 10.1038/32588, 9521319.
7. Winzler C, Rovere P, Rescigno M, Granucci F, Penna G, Adorini L, Zimmermann VS, Davoust J, Ricciardi-Castagnoli P. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J Exp Med 1997, 185:317-328. 10.1084/jem.185.2.317, 2196118, 9016880.
8. Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR, Qin S, Lanzavecchia A. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 1998, 28:2760-2769. 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N, 9754563.
9. O'Doherty U, Peng M, Gezelter S, Swiggard WJ, Betjes M, Bhardwaj N, Steinman RM. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 1994, 82:487-493. 1414873, 7525461.
10. Penna G, Vulcano M, Roncari A, Facchetti F, Sozzani S, Adorini L. Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells. J Immunol 2002, 169:6673-6676.
11. Steinman RM. Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation. Mt Sinai J Med 2001, 68:160-166.
12. Robinson SP, Patterson S, English N, Davies D, Knight SC, Reid CD. Human peripheral blood contains two distinct lineages of dendritic cells. Eur J Immunol 1999, 29:2769-2778. 10.1002/(SICI)1521-4141(199909)29:09<2769::AID-IMMU2769>3.0.CO;2-2, 10508251.
13. Kwok SK, Lee JY, Park SH, Cho ML, Min SY, Park SH, Kim HY, Cho YG. Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus. Arthritis Res Ther 2008, 10:R29. 10.1186/ar2382, 18321389.
14. Decker P, Kotter I, Klein R, Berner B, Rammensee HG. Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2006, 45:1087-1095. 10.1093/rheumatology/kel061, 16527880.
15. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 2001, 294:1540-1543. 10.1126/science.1064890, 11711679.
16. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725. 10.1002/art.1780400928, 9324032.
17. Schned ES, Glickstein SL, Doyle MA. Derivation of the SLEDAI. Arthritis Rheum 1993, 36:877-878. 10.1002/art.1780360623, 8507232.
18. Jin Y, Fuller L, Ciancio G, Burke GW, Tzakis AG, Ricordi C, Miller J, Esquenzai V. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow. Hum Immunol 2004, 65:93-103. 10.1016/j.humimm.2003.11.002, 14969764.
19. Ponchio L, Duma L, Oliviero B, Gibelli N, Pedrazzoli P, Robustelli della Cuna G. Mitomycin C as an alternative to irradiation to inhibit the feeder layer growth in long-term culture assays. Cytotherapy 2000, 2:281-286. 10.1080/146532400539215, 12042037.
20. Chen W, Antonenko S, Sederstrom JM, Liang X, Chan AS, Kanzler H, Blom B, Blazar BR, Liu YJ. Thrombopoietin cooperates with FLT3-ligand in the generation of plasmacytoid dendritic cell precursors from human hematopoietic progenitors. Blood 2004, 103:2547-2553. 10.1182/blood-2003-09-3058, 1510954, 14670916.
21. Gilliet M, Boonstra A, Paturel C, Antonenko S, Xu X-L, Trinchieri G, O'Garra A, Liu Y-J. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J Exp Med 2002, 195:953-958. 10.1084/jem.20020045, 2193725, 11927638.
22. Pulendran B, Banchereau J, Burkeholder S, Kraus E, Guinet E, Chalouni C, Caron D, Maliszewski C, Davoust J, Fay J, Palucka K. Flt3-ligand and granulocyte colony-stimulating factor mobilize distinct human dendritic cell subsets in vivo. J Immunol 2000, 165:566-572.
23. Kwok SK, Lee JY, Park SH, Cho ML, Min SY, Kim HY, Cho YG. Dysfunctional interferon-alpha production by peripheral plasmacytoid dendritic cells upon Toll-like receptor-9 stimulation in patients with systemic lupus erythematosus. Arthritis Res Ther 2008, 10:R29. 10.1186/ar2382, 2453773, 18321389.
24. Jin O, Kavikondala S, Sun L, Fu R, Mok MY, Chan A, Yeung J, Lau CS. Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression. Lupus 2008, 17:654-662. 10.1177/0961203308089410, 18625638.
25. Ding D, Mehta H, McCune WJ, Kaplan MJ. Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J Immunol 2006, 177:5878-5889.
26. Datta SK, Zhang L, Xu L. T-helper cell intrinsic defects in lupus that break peripheral tolerance to nuclear autoantigens. J Mol Med 2005, 83:267-278. 10.1007/s00109-004-0624-2, 15630591.
27. Vallin H, Blomberg S, Alm GV, Cederblad B, Ronnblom L. Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells. Clin Exp Immunol 1999, 115:196-202. 10.1046/j.1365-2249.1999.00772.x, 1905199, 9933442.
28. Obermoser G, Schwingshackl P, Weber F, Stanarevic G, Zelger B, Romani N, Sepp N. Recruitment of plasmacytoid dendritic cells in ultraviolet irradiation-induced lupus erythematosus tumidus. Br J Dermatol 2009, 160:197-200. 10.1111/j.1365-2133.2008.08873.x, 19016699.
29. Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL. Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 2001, 159:237-243. 1850412, 11438470.
30. Monrad SU, Rea K, Thacker S, Kaplan MJ. Myeloid dendritic cells display downregulation of C-type lectin receptors and aberrant lectin uptake in systemic lupus erythematosus. Arthritis Res Ther 2008, 10:R114. 10.1186/ar2517, 2592801, 18811944.
31. Crispin JC, Alcocer-Varela J. The role myeloid dendritic cells play in the pathogenesis of systemic lupus erythematosus. Autoimmun Rev 2007, 6:450-456. 10.1016/j.autrev.2007.01.014, 17643932.
32. Koller M, Zwolfer B, Steiner G, Smolen JS, Scheinecker C. Phenotypic and functional deficiencies of monocyte-derived dendritic cells in systemic lupus erythematosus (SLE) patients. Int Immunol 2004, 16:1595-1604. 10.1093/intimm/dxh160, 15381672.
33. Ronnblom L, Alm GV. A pivotal role for the natural interferon {alpha}-producing cells (plasmacytoid dendritic cells) in the pathogenesis of lupus. J Exp Med 2001, 194:F59-F64. 10.1084/jem.194.12.f59, 2193578, 11748288.
34. Guo J, Cai M. [Generation of CD14+ dendritic cells in vitro with GM-CSF and IL-4]. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2002, 19:276-279.
35. Ferlazzo G, Klein J, Paliard X, Wei WZ, Galy A. Dendritic cells generated from CD34+ progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-alpha are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells. J Immunother 2000, 23:48-58. 10.1097/00002371-200001000-00007, 10687137.
36. Lardon F, Snoeck HW, Berneman ZN, Van Tendeloo VF, Nijs G, Lenjou M, Henckaerts E, Boeckxtaens CJ, Vandenabeele P, Kestens LL, Van Bockstaele DR, Vanham GL. Generation of dendritic cells from bone marrow progenitors using GM-CSF, TNF-alpha, and additional cytokines: antagonistic effects of IL-4 and IFN-gamma and selective involvement of TNF-alpha receptor-1. Immunology 1997, 91:553-559. 10.1046/j.1365-2567.1997.00295.x, 1363875, 9378494.
37. Kiertscher SM, Roth MD. Human CD14+ leukocytes acquire the phenotype and function of antigen-presenting dendritic cells when cultured in GM-CSF and IL-4. J Leukoc Biol 1996, 59:208-218.
38. Weigel BJ, Nath N, Taylor PA, Panoskaltsis-Mortari A, Chen W, Krieg AM, Brasel K, Blazar BR. Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses. Blood 2002, 100:4169-4176. 10.1182/blood-2002-04-1063, 12393694.
39. Brasel K, De Smedt T, Smith JL, Maliszewski CR. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 2000, 96:3029-3039.
40. Shurin MR, Pandharipande PP, Zorina TD, Haluszczak C, Subbotin VM, Hunter O, Brumfield A, Storkus WJ, Maraskovsky E, Lotze MT. FLT3 ligand induces the generation of functionally active dendritic cells in mice. Cell Immunol 1997, 179:174-184. 10.1006/cimm.1997.1152, 9268501.
41. Yanagihara S, Komura E, Nagafune J, Watarai H, Yamaguchi Y. EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J Immunol 1998, 161:3096-3102.
42. Jang MH, Sougawa N, Tanaka T, Hirata T, Hiroi T, Tohya K, Guo Z, Umemoto E, Ebisuno Y, Yang BG, Seoh JY, Lipp M, Kiyono H, Miyasaka M. CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J Immunol 2006, 176:803-810.
43. Ronnblom L, Alm GV. The natural interferon-alpha producing cells in systemic lupus erythematosus. Hum Immunol 2002, 63:1181-1193. 10.1016/S0198-8859(02)00757-7, 12480262.
44. Blomberg S, Eloranta ML, Magnusson M, Alm GV, Ronnblom L. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Rheum 2003, 48:2524-2532. 10.1002/art.11225, 13130472.
45. Niewold TB, Hua J, Lehman TJ, Harley JB, Crow MK. High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun 2007, 8:492-502. 10.1038/sj.gene.6364408, 2702174, 17581626.
46. Sun LY, Zhou KX, Feng XB, Zhang HY, Ding XQ, Jin O, Lu LW, Lau CS, Hou YY, Fan LM. Abnormal surface markers expression on bone marrow CD34+ cells and correlation with disease activity in patients with systemic lupus erythematosus. Clin Rheumatol 2007, 26:2073-2079. 10.1007/s10067-007-0621-2, 17447103.
47. Fan H, Zhang C, Li J, Bi L, Qin L, Wu H, Hu Y. Gelatin microspheres containing TGF-beta3 enhance the chondrogenesis of mesenchymal stem cells in modified pellet culture. Biomacromolecules 2008, 9:927-934. 10.1021/bm7013203, 18269244.
48. Djouad F, Charbonnier LM, Bouffi C, Louis-Plence P, Bony C, Apparailly F, Cantos C, Jorgensen C, Noel D. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 2007, 25:2025-2032. 10.1634/stemcells.2006-0548, 17510220.
49. Sun LY, Zhang HY, Feng XB, Hou YY, Lu LW, Fan LM. Abnormality of bone marrow-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Lupus 2007, 16:121-128. 10.1177/0961203306075793, 17402368.
50. Lian ZX, Kikuchi K, Yang GX, Ansari AA, Ikehara S, Gershwin ME. Expansion of bone marrow IFN-alpha-producing dendritic cells in New Zealand Black (NZB) mice: high level expression of TLR9 and secretion of IFN-alpha in NZB bone marrow. J Immunol 2004, 173:5283-5289.